CannLabs, Inc.
CANL · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $6,505 | $26,834 | $24,085 | $3,121 |
| - Cash | $651 | $538 | $499 | $353 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5,854 | $26,296 | $23,586 | $2,767 |
| Revenue | $4,391 | $3,181 | $2,765 | $2,499 |
| % Growth | 38% | 15% | 10.7% | – |
| Gross Profit | $2,063 | $1,698 | $1,246 | $1,447 |
| % Margin | 47% | 53.4% | 45.1% | 57.9% |
| EBITDA | $881 | $723 | $531 | $811 |
| % Margin | 20.1% | 22.7% | 19.2% | 32.4% |
| Net Income | $869 | $713 | $521 | $804 |
| % Margin | 19.8% | 22.4% | 18.8% | 32.2% |
| EPS Diluted | 0.001 | 0.001 | 0.001 | 0.013 |
| % Growth | 22.2% | -18.2% | -91.5% | – |
| Operating Cash Flow | $773 | $533 | $571 | $551 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | $773 | $533 | $571 | $551 |